BioIVT is a leading provider serving the life science and diagnostic industries, with a strong focus on healthy control and disease-state biospecimens, including human and animal tissues and tissue derivatives, ADME-Tox products and research services, cell and gene therapy products, blood products, and other biological fluids. By combining deep expertise in biospecimen sourcing, cell-based systems, and translational research support, BioIVT helps researchers generate smarter data and accelerate progress in drug discovery, biomarker research, and precision medicine. Its official portfolio spans biofluids, cell products, exosomes, media and reagents, molecular products, subcellular fractions and enzymes, and tissue solutions. 

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of BioIVT products.

⇨ Inquire or Order immediately ⇦

●Biofluids (Blood-Derived)

BioIVT offers human and animal blood-derived biospecimens for biomarker discovery and preclinical research, including whole blood, plasma, serum, and other blood-based sample types. The portfolio covers a wide range of materials such as bone marrow, buffy coats, cord blood, leukopaks, menstrual blood, plasma and serum, platelets, red blood cells, and whole blood, supporting diverse study designs and translational workflows. 

●Biofluids (Other)

BioIVT also provides ready-to-ship inventories of normal human and animal biofluids beyond blood-derived specimens. These include gastrointestinal biofluids, lipoaspirate, ocular biofluids, reproductive biofluids, respiratory fluids, saliva, transcellular fluids, urine, and other specialty sample types that give researchers convenient access to clinically relevant biological materials. 

●Cell Products

BioIVT supplies an extensive range of cell products, including adipocytes, BMMC, cell extracts, conditioned media, dissociated tumor cells, endothelial cells, epithelial cells, fibroblasts, HEPATOMUNE® cultures, HEPATOPAC® cultures, hepatocytes, immortalized cancer cell lines, keratinocytes, melanocytes, musculoskeletal cells, non-parenchymal cells, ocular cells, PBMCs, pericytes, progenitor cells, purified immune cell subsets, renal cells, respiratory cells, skin cells, stem cells, tissue-derived immune cells, and transport-ready products. This broad portfolio is designed to meet the needs of multiple research areas, from ADME-Tox and immunology to oncology and regenerative medicine. 

●Exosomes

BioIVT offers exosomes from multiple sources, including human blood, mesenchymal stem cells, human umbilical cord blood serum, placenta-derived materials, and progenitor cell-related sources. The company also provides broad characterization services for exosome lots, including particle size and concentration analysis, surface protein profiling, miRNA expression and sequencing, LC/MS-based proteomics and lipidomics, electron microscopy, stability testing, Western blotting for specific target proteins, and a variety of functional assays. 

●Media / Reagents / Kits

BioIVT provides media, sera, and ready-to-use kits to support cell culture and related workflows. Its offering also includes ADME media and reagents for hepatocyte incubation, thawing, and seeding, as well as research chemicals such as high-quality cytochrome P450 substrates and corresponding metabolites used in early drug discovery and candidate selection workflows. 

●Molecular Products

BioIVT molecular products include materials such as total RNA, disease-focused total nucleic acid products, and metabolism-related RNA samples for gene expression studies and disease mechanism research. These molecular products are intended to provide high-quality starting material for a wide range of downstream molecular biology applications. 

●Subcellular Fractions and Recombinant Enzymes

This product line includes homogenates, microsomes, S9 fractions, cytosol, non-CYP recombinant enzymes, recombinant cytochrome P450 enzymes, and related cellular materials. These subcellular fractions are prepared to retain relevant biological activity and are widely used in drug metabolism, enzyme activity studies, and in vitro ADME research. 

●Tissue

BioIVT provides both human tissue and animal tissue products. Its ASTERAND® human tissue portfolio covers multiple organ systems and disease areas, including skin, soft tissue, urinary system, central nervous system, endocrine glands, gastrointestinal tract, head and neck, liver, lymphatic tissues, breast, musculoskeletal tissues, reproductive tissues, and respiratory tissues. In addition, BioIVT offers custom animal tissue preparations from commercially available research models, including tissues such as brain, kidney, lung, intestine, heart, and skin, giving researchers flexible access to relevant in vivo-derived materials. 

■ Product List